BRAF and cancer: Other cancers with dominant BRAF mutation but at much lower mutation rate included COADREAD (10.4%), LUAD (7.2%), UCEC (4.7%), BLCA (3.2%), STAD (3.0%), LUSC (2.9%), CHOL (2.8%) and DLBC (2.1%).